🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026

SHA:688765 Revenue

Wuhan Healthgen Biotechnology had revenue of 9.14M CNY in the quarter ending June 30, 2026, with 43.77% growth. This brings the company's total for the last twelve months to 53.43M, up 88.16% year-over-year. In the year 2025, Wuhan Healthgen Biotechnology had annual revenue of 47.86M with 89.80% growth. That makes Wuhan Healthgen Biotechnology the 38,315th largest company in the world by revenue and 5,134th in China.

Revenue (ttm)
53.43M
Revenue Growth
+88.16%
P/S Ratio
171.77
Revenue / Employee
192.18K
Employees
278
Market Cap
9.18B

Revenue Chart

Revenue by Geography

  • China 41.70M 87.1%
  • Overseas 6.16M 12.9%
Fiscal year ended Dec 31, 2025 See the full SHA:688765 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.86M22.65M89.80%
Dec 31, 202425.22M952.02K3.92%
Dec 31, 202324.26M10.86M81.08%
Dec 31, 202213.40M-12.12M-47.49%
Dec 31, 202125.52M3.95M18.33%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.